Cardiac graft vasculopathy. Aetiologic factors and therapeutic approaches

Acta Cardiologica

Volumn 53, Issue 1, 1998, Pages 37-43

  Conraads, Viviane ^a   Lahaye, Ingrid ^a   Rademakers, Frank ^a   Heuten, Hilde ^a   Rodrigus, Ines ^a   Vrints, Christiaan ^a   Moulijn, Adriaan ^a  

^a ANTWERP UNIVERSITY HOSPITAL   (Belgium)

Author keywords

Cardiac graft; Vasculopathy

Indexed keywords

CALCIUM CHANNEL BLOCKING AGENT; CHOLESTEROL; CORTICOSTEROID; CYCLOSPORIN; CYCLOSPORIN A; DILTIAZEM; TRIACYLGLYCEROL;

ANGIOCARDIOGRAPHY; ARTICLE; ATHEROSCLEROSIS; CORONARY ARTERY BLOOD FLOW; CYTOMEGALOVIRUS; DIABETES MELLITUS; DIET THERAPY; GRAFT INFECTION; GRAFT REJECTION; HEART DISEASE; HEART TRANSPLANTATION; HUMAN; HYPERLIPIDEMIA; HYPERTENSION; IMMUNE RESPONSE; INTRAVASCULAR ULTRASOUND; LIPID METABOLISM; OBESITY; ORGAN DONOR; REOPERATION; RESTENOSIS; REVASCULARIZATION; RISK FACTOR; SURVIVAL TIME; THROMBOCYTE AGGREGATION; VASCULAR DISEASE;

GRAFT OCCLUSION, VASCULAR; GRAFT REJECTION; HEART TRANSPLANTATION; HUMANS; RISK FACTORS;

EID: 0031730499     PISSN: 00015385     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (41)

1. Akosah KO, Mohanty PK, Funai JT, Jesse RL, Minisi AJ, Crandall CW, Kirchberg D, Guerraty A and Slater D. Noninvasive detection of transplant coronary artery disease by dobutamine stress echocardiography. J Heart Lung Transplant 1994; 13: 1024.
2. Botas J, Pinto FJ, Chenzbraun A, Liang D, Schroeder JS, Oesterle SN, Alderman EL, Popp RL and Yeung AC. Influence of preexistent donor coronary artery disease on the progression of transplant vasculopathy. An intravascular ultrasound study. Circulation 1995; 92: 1126.
3. Catapano AL. Calcium antagonists and atherosclerosis. Eur H J 1997; 18: A80.
4. Constanzo-Nordin MR. Cardiac allograft vasculopathy: relationship with acute cellular rejection and histocompatibility. J Heart Lung Transplant 1992; 11: S90.
5. De Lorgeril M, Boissonnat P, Guidollet J, Dureau G and Renaud S. Evaluation of ticlodipine, a novel inhibitor of platelet function, in heart transplant recipients. Transplantation 1993; 55: 1195.
6. De Lorgeril M, Boissonnat P, Mamelle N, Martin J-L, Monjaud I, Guidollet J, Dureau G, Ninet J and Renaud S. Platelet aggregation and HDL cholesterol are predictive of acute coronary events in heart transplant recipients. Circulation 1994; 89: 2590.
7. Etingin OR and Hajjar DP. Nifedipine increases cholesteryl ester hydrolytic activity in lipid-laden rabbit arterial smooth muscle cells. J Clin Invest 1985; 75: 1554.
8. Everett JP, Herschberger RE, Norman DJ, Chou S, Ratkovec RP, Cobanoglu A, Ott GY and Hosenpud JD. Prolonged cytomegalo-virus infection with viremia is associated with development of cardiac allograft vasculopathy. J Heart Lung Transplant 1992; 11: S133.
9. Frederich R, Toyoda M, Czer L, Young S, Galera O, Galfayan K, Trento A and Jordan S. Clinical significance of antibodies to human vascular endothelial cells in cardiac allograft recipients: correlation with type of rejection and allograft vasculopathy. Symposia, 16th International Society of Heart and Lung Transplantation Convention: New York, 1995.
10. Gao SZ, Schroeder JS, Alderman EL, Hunt SA, Silverman JF, Wiederhold V and Stinson EB. Clinical and laboratory correlates of accelerated coronary artery disease in the cardiac transplant patient. Circulation 1987; 76 (Suppl. V): V-56.
11. Gao SZ, Alderman EL, Schroeder JS, Silverman JF and Hunt SA. Accelerated coronary vascular disease in the heart transplant patient: coronary arteriographic findings. J Ann Coll Cardiol 1988; 12: 334.
12. Gao SZ, Schroeder JS, Hunt S and Stinson EB. Retransplantation for severe accelerated coronary artery disease in heart transplant recipients. Am J Cardiol 1988; 62: 876.
13. Gao SZ, Schroeder JS and Alderman EL. Prevalence of accelerated coronary artery disease in heart transplant survivors. Circulation 1989; 80 III: 100.
14. Gao SZ, Schroeder JS, Hunt Valantine HA, Hill IR and Stinson EB. Influence of graft rejection on incidence of accelerated graft coronary artery disease: a new approach to analysis. J Heart Lung Transplant. 1993; 12: 1029.
15. Gregory CR, Huie P, Billingham ME and Morris RE. Rapamycin inhibits arterial intimal thickening caused by both allo-immune and mechanical injury. Transplantation 1993; 55: 1409.
16. Halle AA, DiSciascio G, Massin EK, Wilson RF, Johnson MR, Sullivan H, Bourge RC, Kleiman NS, Miller LW, Aversano TR, Wray RB, Hunt SA, Weston MW, Davies RA, Rincon G, Crandall CC, Cowley MJ, Kubo SH, Fisher SG and Betrovec GW. Coronary angioplasty, atherectomy and bypass surgery in cardiac transplant recipients. J Am Coll Cardiol 1995; 26: 120.
17. Heroux AL, Silverman P, Constanzo MR, O'Sullivan J, Johnson MR, Liao Y, McKiernan TL, Balhan JE, Leya FS, Mullen GM, Kao WG and Johnson SA. Intracoronary ultrasound assessment of morphological and functional abnormalities associated with cardiac allograft vasculopathy. Circulation 1994; 89: 272.
18. Herregods MC, Anastassiou I, Van Cleemput J, Bijnens B, De Geest H, Daenen W and Vanhaecke J. Dobutamine stress echocardiography after heart transplantation. J Heart Lung Transplant 1994; 13: 1039.
19. Hoyt G, Gollin G, Billingham M, Miller DC and Jamieson SW. Effects of anti-platelet regimens in combination with cyclosporine on heart allograft vessel disease. J Heart Lung Transplant 1984; 4: 54.
20. Johnson MR. Transplant coronary disease: nonimmunologic risk factors. J Heart Lung Transplant 1992; 11: S124.
21. Keogh AM. Proximal and mid-vessel coronary artery disease in the transplanted heart. J Heart Lung Transplant 1992; 11: S87.
22. Kobashigawa JA, Katznelson S, Laks H, Johnson JA, Yeatman L, Wang XM, Chia D, Terasaki PI, Sabad AS, Cogert GA, Trosian K, Hamilton MA, Moriguchi JD, Kawata N, Hage A, Drinkwater DC and Stevenson LW. Effect of pravastatin on outcomes after cardiac transplantation. N Engl J Med 1995; 333: 621.
23. Koskinen PK, Nieminen MS, Krogerus LA, Lemström KB, Mattila SP, Häyry PJ and Lautenschlager IT. Cytomegalovirus infection and accelerated cardiac allograft vasculopathy in human cardiac allografts. J Heart Lung Transplant 1993; 12: 724.
24. McDonald P, Keogh A, Connell J, Harvison A, Richens D and Spratt P. Dilthiazem coadministration reduces cyclosporine toxicity after heart transplantation: a prospective randomised study. Transplant Proc 1992; 24: 2259.
25. McKillop JH and Goris CM. Thallium-201 myocardial imaging in patients with previous cardiac transplantation. Clin Radiol 1981; 32: 447.
26. Mehra MR, Ventura HO, Chambers R, Collins TJ, Ramee SR, Kates MA, Smart FW and Stapleton DD. Predictive model to assess risk for cardiac allograft vasculopathy: an intravascular ultrasound study. J Am Coll Cardiol 1995; 26: 1537.
27. Mills RP, Billet JP and Nichols WW. Endothelial dysfunction early after heart transplantation, assessment with intravascular ultrasound and doppler. Circulation 1992; 86: 1171.
28. Parameshwar J, Foote J, Sharples L, Wallwork J, Large S and Schofield P. Lipids, lipoprotein (a) and coronary artery disease in patients following cardiac transplantation. Transpl Int 1996; 9: 48.
29. Pinto FJ, Chenzbraun A, Botas J, Valantine HA, St. Goar FG, Alderman EL, Oesterle SN, Schroeder JS and Popp RL. Feasibility of serial intracoronary ultrasound imaging for assessment of progression of intimal proliferation in cardiac transplant recipients. Circulation 1994; 90: 2348.
30. Sandhu JS, Uretsky BF, Reddy PS, Denys BG, Ruffner RJ, Breisblatt WM, Zerbe TR, Kormos RL, Armitage JM, Hardesty RL and Griffith BP. Potential limitations of percutaneous transluminal coronary angioplasty in heart transplant recipients. Am J Cardiol 1992; 69: 1234.
31. Schroeder JS, Gao S-Z, Alderman EL, Hunt S, Johnstone I, Boothroyd DB, Wiederhold V and Stinson EB. A preliminary study of dilthiazem in the prevention of coronary artery disease in heart-transplant recipients. N Engl J Med 1993; 328: 164.
32. Schroeder JS. Prevention of transplant coronary disease with dilthiazem: clinical and intravascular findings. Drugs of Today 1995; 31 (Suppl. B): 33.
33. Smart FW, Ballantyne CP, Cocanougher B, Farmer JA, Sekela ME, Noon GP, Young JB et al. Insensitivity of noninvasive tests to detect coronary artery vasculopathy after heart transplant. Am J Cardiol 1991; 67: 243.
34. Spes CH, Mudra H, Schnaack SD, Klauss V, Reichle FM, Überfuhr P, Angermann CE and Theissen K. Can annual surveillance coronary angiography after heart transplantation be substituted by noninvasive dobutamine stress echocardiography? Symposia, 15th International Society of Heart and Lung Transplantation Convention: San Francisco, 1995.
35. Stempfle HU, Klauss V, Mudra H, Jung P, Rieber J, Scholtz S, Meiser B, Angermann CE and Theisen K. The influence of HLA compatibility on the incidence of cardiac allograft vasculopathy detected by intravascular ultrasound. Symposia, 16th International Society of Heart and Lung Transplantalion Convention New York, 1996.
36. St. Goar FG, Pinto FJ, Alderman EL, Valantine HA, Schroeder JS, Gao S-Z, Stinson EB and Popp RL. Intracoronary ultrasound in cardiac transplant recipients. In vivo evidence of "angiographically silent" intimai thickening. Circulation 1992; 85: 979.
37. Uretsky BF, Murali S, Reddy S, Rabin B, Lee A, Griffith BP, Hardesty RL, Trento A and Bahnson HT. Development of coronary artery disease in cardiac transplant patients receiving immunosuppressive therapy with cyclosporine and prednisone. Circulation 1987; 76: 827.
38. Valantine HA, Keogh A, McIntosh N, Hunt S, Oyer P and Schroeder J. Cost containment: coadministration of dilthiazem with cyclosporine after heart transplantation. J Heart Lung Transplant 1992; 11: 1.
39. Valantine HA, Gao S-Z, Gopinathan SK, Renlund DG, Hunt SA, Merigan TC, Oyer P, Stinson EB and Schroeder JS. Impact of prophylactic immediate post-transplant ganciclovir on development of transplant atherosclerosis: a randomized placebo-controlled study. J Heart Lung Transplant 1996; 15: S72.
40. Vanhaecke J, Van Cleemput J, Van Lierde J, Daenen W and De Geest H. Safety and efficacy of low dose simvastatin in cardiac transplant recipients treated with cyclosporine. Transplantalion 1994; 58: 42.
41. Von Scheidt W, Kemkes BM, Reichart B and Erdmann E. Percutaneous transluminal coronary angioplasty of focal coronary lesions after cardiac transplantation. Clin Investig 1993; 71: 524.